Perfusion Systems Market- Growth opportunity due to Increasing Pharmaceutical Research and Rising Preference for Continuous Manufacturing

1
MarketsandMarkets Presents
Perfusion Systems Market- Growth opportunity due
to Increasing Pharmaceutical Research and Rising
Preference for Continuous Manufacturing
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
2
The "Perfusion Systems Market (Cardiopulmonary
Perfusion, by Component (Heart-lung Machines,
Oxygenators), Ex Vivo Organ Perfusion, Technique
(Hypothermic, Normothermic), Cell Perfusion, by
Type (Bioreactor, Microfluidic)) - Global
Forecast to 2021", report provides a detailed
overview of the major drivers, restraints,
challenges, opportunities, current market trends,
and strategies impacting the Perfusion System
market along with the estimates and forecasts of
the revenue and market share analysis. Download
The PDF Brochure_at_ http//www.marketsandmarkets.com
/pdfdownload.asp?id164273069 The global
perfusion systems market is expected to reach USD
1,198.8 Million by 2021 from USD 989.4 Million in
2016, at a CAGR of 3.9.
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
3
Industry growth is driven by the growth of the
market can be attributed to the increasing
prevalence of cardiovascular respiratory
diseases, initiatives by governments NGOs to
encourage organ donation, increasing investment
in cell-based research, and developments in
biologics manufacturing. The high cost of organ
transplantation and organ supply-demand gap,
however, are expected to hinder the growth of the
market. Request Sample_at_ http//www.marketsandmar
kets.com/requestsample.asp?id164273069 The
perfusion systems market is segmented on the
basis of type (namely cardiopulmonary perfusion
systems, ex vivo organ perfusion systems, and
cell perfusion systems) and region. The
oxygenators segment accounted for the largest
share of the cardiopulmonary perfusion systems
market in 2016. Based on technique, the ex vivo
organ perfusion systems market is segmented into
hypothermic machine perfusion and normothermic
machine perfusion. 
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
4
The hypothermic machine perfusion segment held
the largest share of the ex vivo organ perfusion
systems market in 2016 and is also projected to
grow at the highest CAGR during the forecast
period. The global cell perfusion systems market
is segmented based on the type, as bioreactor
perfusion systems, microfluidic perfusion
systems, gravity or pressure-driven perfusion
systems, and small-mammal organ perfusion
systems. The bioreactor perfusion systems segment
held the largest share of the cell perfusion
systems market in 2016 and is projected to
register the highest CAGR during the forecast
period.
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
5
Geographically, North America is estimated to
account for the largest share of the global
market, followed by Europe.  The Asia-Pacific
region is expected to witness the highest growth
in the market during the forecast period.  This
growth will be particularly centered on China,
Japan, and India. The major players in Perfusion
System market include Getinge AB (Sweden),
Medtronic plc (Ireland), LivaNova PLC (U.K.),
Terumo Corporation (Japan), and XENIOS AG
(Germany). The major players in the ex vivo organ
perfusion systems market are Lifeline Scientific,
Inc. (U.S.) and XVIVO Perfusion AB (Sweden),
while, Repligen Corporation (U.S.), Spectrum
Laboratories, Inc. (U.S.), Merck KGaA (Germany),
Harvard Bioscience, Inc. (U.S.), and ALA
Scientific Instruments, Inc. (U.S.)
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/pe
rfusion-system-market-164273069.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
8
(No Transcript)